OHB OHB AG

EQS-News: OHB SE: 3-month interim report 2024

EQS-News: OHB SE / Key word(s): Quarter Results
OHB SE: 3-month interim report 2024

08.05.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


OHB SE: 3-month interim report 2024
  • Total revenues of EUR 207 million mark all-time high
  • Equity ratio increased to 35 % (+7 % compared to the same period of the previous year)

Bremen, May 8, 2024. The OHB Group (ISIN: DE0005936124, Prime Standard) generated total revenues of EUR 206.7 million in the first three months, up 2 % on the previous year (EUR 202.4 million). The operating result (EBITDA) decreased from EUR 21.5 million in the previous year to EUR 19.3 million. The operating EBITDA margin thus declined to 9.4 % in the reporting period, compared to 10.6 % in the same period of the previous year. EBIT deteriorated to EUR 10.2 million in the first three months of the current fiscal year, compared to EUR 12.5 million in the previous year. The corresponding EBIT margin decreased accordingly to 4.9 %, compared to 6.2 % in the same period of the previous year.

The Group's firm order backlog stood at EUR 1,725 million after three months of fiscal year 2024, down from EUR 1,764 million in the previous year. Of this amount, EUR 1,429 million is attributable to the SPACE SYSTEMS segment, EUR 162 million to the AEROSPACE segment and EUR 133 million to the DIGITAL segment. As of March 31, 2024, the OHB Group's total assets stood at EUR 1,265.7 million, down around 6 % from December 31, 2023 (EUR 1,340.1 million). The increase in equity from EUR 438.0 million to EUR 442.6 million resulted in an equity ratio of 35.0 % as of March 31, 2024, up from 32.7 % at year-end on December 31, 2023.

The voluntary public takeover offer by Orchid Lux HoldCo S.à r.l. is progressing according to plan. At present, approvals for foreign direct investments in two of a total of ten countries are still pending.

In the past quarter, the Group companies in the SPACE SYSTEMS segment strengthened OHB's own strong position in the field of Earth observation by being awarded orders for twelve further satellites for the IRIDE constellation and a contract for the preparation of the next generation of Sentinel-2 satellites for the European Copernicus constellation. As the main partner for the LEO-PNT demonstration mission, OHB is using its own expertise from the Galileo navigation program to lay the foundations for new fields of application such as autonomous driving. In addition, several Group companies in both the SPACE SYSTEMS and AEROSPACE segments are involved in various developments aimed at enhancing the efficiency of launch vehicles. Furthermore, Rocket Factory Augsburg successfully completed the test campaign for the upper stage of its own launcher RFA ONE in the past quarter and is currently working towards the first flight this coming summer. In the DIGITAL segment, OHB was able to expand its business with applications based on Earth observation data as the project coordinator for Baltic GTIF.

The Management Board expects consolidated total revenues of between EUR 1,300 million and EUR 1,400 million in 2024. Adjusted for special effects in both cases, the EBITDA margin and the EBIT margin should reach > 8.5 % and > 6.0 % respectively. At this point in time, the Management Board assumes that the financial position and net assets will continue to develop well.

Key performance indicators at a glance
in EUR 000 3M 2024 3M 2023 +/- 3M
Revenues 203,126 197,170 +3 %
Total revenues 206,725 202,350 +2 %
EBITDA 19,342 21,542 -10 %
EBIT 10,230 12,542 -18 %
Share of OHB SE shareholders in net profit for the period 4,767 7,074 -33 %
Earnings per share
in EUR
0.25 0.41 -39 %
Cash and cash equivalents 23,749 40,837 -42 %



Contact:
Media representatives:
Marianne Radel
Corporate Communications
Phone: 59
Email:


Investors and analysts:
Marcel Dietz
Investor Relations
Phone: 26
Email:


08.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: OHB SE
Manfred-Fuchs-Platz 2-4
28359 Bremen
Germany
Phone:
E-mail:
Internet:
ISIN: DE0005936124
WKN: 593612
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1897873

 
End of News EQS News Service

1897873  08.05.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1897873&application_name=news&site_id=research_pool
EN
08/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OHB AG

 PRESS RELEASE

EQS-News: OHB SE: 9-month interim report 2024

EQS-News: OHB SE / Key word(s): 9 Month figures OHB SE: 9-month interim report 2024 12.11.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. OHB SE: 9-month interim report 2024 Adjusted EBITDA of EUR 72.5 million, up 13 % on the previous year Order backlog grows by 22 % year-on-year to EUR 2,120 million. Voluntary public takeover offer by Orchid Lux HoldCo S.à r.l. successfully completed The OHB Group (ISIN: DE0005936124, Prime Standard) generated total revenues of EUR 715.8 million in the first nine months, down 3 % on the pre...

 PRESS RELEASE

EQS-News: OHB SE: 9-Monats-Zwischenbericht 2024

EQS-News: OHB SE / Schlagwort(e): 9-Monatszahlen OHB SE: 9-Monats-Zwischenbericht 2024 12.11.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. OHB SE: 9-Monats-Zwischenbericht 2024 Bereinigtes EBITDA in Höhe von EUR 72,5 Mio. gegenüber dem Vorjahr um 13 % erhöht Auftragsbestand wächst im Vorjahresvergleich um 22 % und erreicht EUR 2.120 Mio. Freiwilliges öffentliches Übernahmeangebot der Orchid Lux HoldCo S.à r.l. erfolgreich vollzogen Der OHB-Konzern (ISIN: DE0005936124, Prime Standard) erzielte nach neun Monaten eine g...

 PRESS RELEASE

EQS-News: KKR hat alle regulatorischen Freigaben für Einstieg bei OHB ...

EQS-News: OHB SE / Schlagwort(e): Übernahmeangebot KKR hat alle regulatorischen Freigaben für Einstieg bei OHB erhalten 27.08.2024 / 19:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. KKR hat alle regulatorischen Freigaben für Einstieg bei OHB erhalten Alle Angebotsbedingungen des freiwilligen öffentlichen Übernahmeangebots sind erfüllt Familie Fuchs bleibt Mehrheitsaktionärin OHB strebt weiterhin Rückzug von der Börse an Das deutsche Raumfahrt- und Technologieunternehmen OHB SE („OHB“) gibt bekannt, dass das Übernahmeangebot ...

 PRESS RELEASE

EQS-News: KKR has received all regulatory approvals for its investment...

EQS-News: OHB SE / Key word(s): Tender Offer KKR has received all regulatory approvals for its investment in OHB 27.08.2024 / 19:30 CET/CEST The issuer is solely responsible for the content of this announcement. KKR has received all regulatory approvals for its investment in OHB All conditions of the voluntary public takeover offer have been fulfilled The Fuchs family remains the majority shareholder OHB still plans to delist from the stock exchange OHB SE ("OHB"), the German space and technology company, announces that the takeover offer ("offer") by KKR will be comp...

 PRESS RELEASE

EQS-News: OHB SE: 6-month interim report 2024

EQS-News: OHB SE / Key word(s): Half Year Report/Half Year Results OHB SE: 6-month interim report 2024 08.08.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. OHB SE: 6-month interim report 2024 Total revenues of EUR 470 million mark all-time high Order backlog remains at a high level of EUR 1.7 billion Adjusted EBITDA reaches EUR 41 million Stabilization in the AEROSPACE segment; EBIT margin of the segment significantly increased compared to the previous year (+33%) Completion of the voluntary public takeover offer by Orchid...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch